BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 32466852)

  • 1. Alteration of CD226/TIGIT immune checkpoint on T cells in the pathogenesis of primary Sjögren's syndrome.
    Deng C; Chen Y; Li W; Peng L; Luo X; Peng Y; Zhao L; Wu Q; Zhang W; Zhang X; Fei Y
    J Autoimmun; 2020 Sep; 113():102485. PubMed ID: 32466852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imbalance of the CD226/TIGIT Immune Checkpoint Is Involved in the Pathogenesis of Primary Biliary Cholangitis.
    Deng C; Li W; Fei Y; Wang L; Chen Y; Zeng X; Zhang F; Li Y
    Front Immunol; 2020; 11():1619. PubMed ID: 32793241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8
    Wang M; Bu J; Zhou M; Sido J; Lin Y; Liu G; Lin Q; Xu X; Leavenworth JW; Shen E
    Clin Immunol; 2018 May; 190():64-73. PubMed ID: 28893624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expansion of circulating peripheral TIGIT+CD226+ CD4 T cells with enhanced effector functions in dermatomyositis.
    Li W; Deng C; Yang H; Lu X; Li S; Liu X; Chen F; Chen L; Shu X; Zhang L; Liu Q; Wang G; Peng Q
    Arthritis Res Ther; 2021 Jan; 23(1):15. PubMed ID: 33413573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased frequency of CCR7
    Wu C; Yang P; Liu H; Xiao W; Zhao L
    Cytokine; 2018 Oct; 110():9-17. PubMed ID: 29684636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The TIGIT/CD226 axis regulates human T cell function.
    Lozano E; Dominguez-Villar M; Kuchroo V; Hafler DA
    J Immunol; 2012 Apr; 188(8):3869-75. PubMed ID: 22427644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased CD4+CD25+bright T cells in peripheral blood of patients with primary Sjogren's syndrome.
    Liu MF; Lin LH; Weng CT; Weng MY
    Lupus; 2008 Jan; 17(1):34-9. PubMed ID: 18089681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the immune checkpoint molecules CD226 and TIGIT in preeclampsia patients.
    Li C; Liu H; Duan Z
    BMC Immunol; 2024 Feb; 25(1):12. PubMed ID: 38326745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced expression of TIGIT but not neuropilin-1 in patients with type 2 diabetes mellitus.
    Hoseini-Aghdam M; Sheikh V; Eftekharian MM; Rezaeepoor M; Behzad M
    Immunol Lett; 2020 Sep; 225():1-8. PubMed ID: 32540486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression of TIGIT on CD14 + monocytes correlates with clinical features and laboratory parameters of patients with primary Sjögren's syndrome.
    Zhao P; Peng C; Chang X; Cheng W; Yang Y; Shen Y; Sun C; Feng X; Liu C; Wu J
    Clin Rheumatol; 2024 Jan; 43(1):297-306. PubMed ID: 37749409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-Cell RNA Sequencing Reveals the Expansion of Cytotoxic CD4
    Hong X; Meng S; Tang D; Wang T; Ding L; Yu H; Li H; Liu D; Dai Y; Yang M
    Front Immunol; 2020; 11():594658. PubMed ID: 33603736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD226 opposes TIGIT to disrupt Tregs in melanoma.
    Fourcade J; Sun Z; Chauvin JM; Ka M; Davar D; Pagliano O; Wang H; Saada S; Menna C; Amin R; Sander C; Kirkwood JM; Korman AJ; Zarour HM
    JCI Insight; 2018 Jul; 3(14):. PubMed ID: 30046006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant IL-35 levels in patients with primary Sjogren's syndrome.
    Guo J; Gu M; Zhang W; Liu Y; Qian C; Deng A
    Scand J Immunol; 2018 Nov; 88(5):e12718. PubMed ID: 30589451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease in CD226 expression on CD4
    Li C; Zhou J; Shao J; Yuan L; Cheng Q; Wang L; Duan Z
    Biosci Trends; 2023 May; 17(2):168-171. PubMed ID: 37081668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human CD4
    Šunina M; Alnek K; Kisand K; Uibo R
    Scand J Immunol; 2021 Sep; 94(3):e13089. PubMed ID: 35971920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of CD4+ CD25+ regulatory T cells in peripheral blood and salivary gland of patients with primary Sjögren's syndrome].
    Li XM; Li XP; Qian L; Wang GS; Zhang H; Zhei ZM; Li Q; Chen K; Wang XQ; Wang YP
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1034-6. PubMed ID: 17672966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cell subsets and dysfunction of regulatory B cells in IgG4-related diseases and primary Sjögren's syndrome: the similarities and differences.
    Lin W; Jin L; Chen H; Wu Q; Fei Y; Zheng W; Wang Q; Li P; Li Y; Zhang W; Zhao Y; Zeng X; Zhang F
    Arthritis Res Ther; 2014 May; 16(3):R118. PubMed ID: 24887143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perturbed CD8
    Tauriainen J; Scharf L; Frederiksen J; Naji A; Ljunggren HG; Sönnerborg A; Lund O; Reyes-Terán G; Hecht FM; Deeks SG; Betts MR; Buggert M; Karlsson AC
    Sci Rep; 2017 Jan; 7():40354. PubMed ID: 28084312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of RORγ positive and negative subsets of CD161+CD4+ T cells in primary Sjögren's syndrome.
    Zhao L; Nocturne G; Haskett S; Boudaoud S; Lazure T; Le Pajolec C; Mariette X; Mingueneau M; Banerjee D
    Rheumatology (Oxford); 2017 Feb; 56(2):303-312. PubMed ID: 27803305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a new regulatory CD4+ T cell subset in primary Sjögren's syndrome.
    Alunno A; Petrillo MG; Nocentini G; Bistoni O; Bartoloni E; Caterbi S; Bianchini R; Baldini C; Nicoletti I; Riccardi C; Gerli R
    Rheumatology (Oxford); 2013 Aug; 52(8):1387-96. PubMed ID: 23674818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.